---
title: "ATCO.MED.B.040 Infectious disease — ANNEX IV – PART ATCO.MED – MEDICAL REQUIREMENTS FOR AIR TRAFFIC CONTROLLERS, ATCO · Avioverse"
description: "Applicants who are HIV positive shall be referred to the licensing authority and may be assessed as fit subject to satisfactory specialist evaluation and…"
url: "https://avioverse.aero/regulations/easa/atco/part-atco-med-medical-requirements-for-air-traffic/subpart-b/atco-med-b-040"
---

# ATCO.MED.B.040 Infectious disease

ANNEX IV – PART ATCO.MED – MEDICAL REQUIREMENTS FOR AIR TRAFFIC CONTROLLERS · Regulation (EU) 2015/340 · EAR revision 14 Jun 2024

IR Implementing rule

## ATCO.MED.B.040 Infectious disease

(a) Applicants who are HIV positive shall be referred to the [licensing authority](https://avioverse.aero/glossary/easa/licensing-authority) and may be assessed as fit subject to satisfactory specialist evaluation and provided the licensing authority has sufficient evidence that the therapy does not compromise the safe exercise of the privileges of the [licence](https://avioverse.aero/glossary/easa/licence).

(b) Applicants diagnosed with or presenting symptoms of infectious disease such as:

(1) acute syphilis;

(2) active tuberculosis;

(3) infectious hepatitis;

(4) tropical diseases;

shall be referred to the licensing authority for an [aero-medical assessment](https://avioverse.aero/glossary/easa/aero-medical-assessment). A fit [assessment](https://avioverse.aero/glossary/easa/assessment) may be considered after full recovery and specialist evaluation provided the licensing authority has sufficient evidence that the therapy does not compromise the safe exercise of the privileges of the licence.

IR · ATCO.MED.B.040 — Regulation (EU) 2015/340 · ATCO Easy Access Rules · EAR revision 14 Jun 2024

AMC Acceptable means of compliance

## AMC1 ATCO.MED.B.040 Infectious disease

(a) Infectious disease — General

In cases of infectious disease, consideration should be given to a history of, or clinical signs indicating, underlying impairment of the immune system.

(b) Tuberculosis

(1) Applicants with active tuberculosis should be assessed as unfit. A fit [assessment](https://avioverse.aero/glossary/easa/assessment) may be considered following completion of therapy.

(2) Applicants with quiescent or healed lesions may be assessed as fit. Specialist evaluation should consider the extent of the disease, the treatment required and possible side effects of medication.

(c) Syphilis

Applicants with acute syphilis should be assessed as unfit. A fit assessment may be considered in the case of those fully treated and recovered from the primary and secondary stages.

(d) HIV positivity

(1) Applicants who are HIV positive may be assessed as fit if a full [investigation](https://avioverse.aero/glossary/easa/investigation) provides no evidence of HIV associated diseases that might give rise to incapacitating symptoms. Frequent review of the immunological status and neurological evaluation by an appropriate specialist should be carried out. A cardiological review may also be required depending on medication.

(2) Applicants with an AIDS defining condition should be assessed as unfit except in individual cases for [revalidation](https://avioverse.aero/glossary/easa/revalidation) of a medical certificate after complete recovery and dependent on the review.

(3) The [aero-medical assessment](https://avioverse.aero/glossary/easa/aero-medical-assessment) of individual cases under (1) and (2) should be dependent on the absence of symptoms or signs of the disease and the acceptability of serological markers. Treatment should be evaluated by a specialist on an individual basis for its appropriateness and any side effects.

(e) Infectious hepatitis

Applicants with infectious hepatitis should be assessed as unfit. A fit assessment may be considered once the applicant has become asymptomatic after treatment and specialist evaluation. Regular review of the liver function should be carried out.

AMC · AMC1 ATCO.MED.B.040 — Regulation (EU) 2015/340 · ED Decision 2015/010/R · ATCO Easy Access Rules · EAR revision 14 Jun 2024

GM Guidance material

## GM1 ATCO.MED.B.040 Infectious disease

HIV INFECTION

(a) There is no requirement for routine testing of HIV status, but testing may be carried out on clinical indication.

(b) If HIV positivity has been confirmed, a process of rigorous [aero-medical assessment](https://avioverse.aero/glossary/easa/aero-medical-assessment) and follow-up should be introduced to enable individuals to continue working provided their ability to exercise their licenced privileges to the required level of safety is not impaired. The operational environment should be considered in the decision-making.

GM · GM1 ATCO.MED.B.040 — Regulation (EU) 2015/340 · ED Decision 2015/010/R · ATCO Easy Access Rules · EAR revision 14 Jun 2024

[All rules in SUBPART B – SPECIFIC REQUIREMENTS FOR CLASS 3 MEDICAL CERTIFICATES](https://avioverse.aero/regulations/easa/atco/part-atco-med-medical-requirements-for-air-traffic/subpart-b)

Consolidated from the EASA Easy Access Rules (revision 14 Jun 2024, extracted 13 Oct 2026) for convenience. Not the official publication — verify against the Official Journal of the European Union and the EASA publications before operational use.